Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04927325
Other study ID # 1165/2021
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 30, 2021
Est. completion date October 10, 2022

Study information

Verified date December 2021
Source Medical University of Vienna
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: In critical care medicine central venous catheters play an important role in the source of infections. In the daily routine prior to the diagnosis the suspicion of catheter related infection is discussed in the medical team due to signs of systemic inflammation or exit site infection like erythema, induration or tenderness. However, if an erythema at exit site of a central line can be quantified with a tablet camera, is unknown. Methods: Standardized set of photos will be taken of 10 central lines with a reddened exit site and 10 catheters without an erythema (as a control over time) with a tablet camera and a single-lens reflex camera. The percentage of usable images between tablet and single-lens reflex camera will be analysed. Furthermore, two independent clinical experts from dermatology will grade blinded de-identied images on a scale from 0 to 4 (0 - no erythema, 1- very faint, 2 - faint, 3 - bright, 4 - very bright). Objectives: The primary objective of this feasibility study aims to analyze the reliability of a tablet camera as a device for quantification of erythema around an exit site.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date October 10, 2022
Est. primary completion date October 10, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult - Jugular CVC or Subclavian CVC - ICU-Admission Exclusion Criteria: - < 18 years - Pregnancy/Lactation - HIV - neutropenia (<1000/m3) - hematologic tumor - dark pigmentation - prone position within the last 24 hours - head/neck-area: cancer, operation, burns or radiation, tattoos

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Set of Photos
A standardized set of photos will be taken with a tablet camera, SLR, thermal camera.

Locations

Country Name City State
Austria Department of Anesthesia, General Intensive Care and Pain Management,Medical University of Vienna Vienna

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Vienna

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of usable images The percentage of useable images of tablet camera compared with single-lens reflex (SLR) camera will be analysed. through study completion, an average of 3 months
Secondary Quantification of the exit site with regards to an erythema scale The secondary objective aims to evaluate the quantification of the exit site regarding to the erythema scale by two independent clinical experts comparing images of tablet and SLR camera.
The erythema will be graded using a visual ordinal scale (grade 0 to grade 4). Grade 0 represents no erythema, whereas grade 4 describes a very bright erythema.
through study completion, an average of 3 months